Valion Bio Inc (VBIO) — Financial Flexibility Index
Valion Bio Inc (VBIO) has a Financial Flexibility Index of -0.15x as of December 2025. Free cash flow of $-2.26 Million (operating CF $-2.29 Million minus capex $25.00K) represents 0% of total liabilities ($14.81 Million). Also explore Valion Bio Inc equity growth rate to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Valion Bio Inc Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for Valion Bio Inc across 7 annual periods. See VBIO equity financing ratio to measure how much of total assets are equity-financed.
Annual Financial Flexibility Index for Valion Bio Inc (2017–2025)
Year-by-year free cash flow to debt coverage for Valion Bio Inc. For the full company profile including market capitalisation, see market value of Valion Bio Inc.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.43x | $-6.42 Million | $-7.00 Million | $14.81 Million | ▲ +97.9% |
| 2024 | -21.05x | $-5.72 Million | $-5.72 Million | $272.00K | ▼ -295.5% |
| 2023 | -5.32x | $-8.39 Million | $-8.51 Million | $1.58 Million | ▼ -34.1% |
| 2022 | -3.97x | $-8.91 Million | $-8.92 Million | $2.25 Million | ▲ +91.7% |
| 2020 | -48.00x | $-1.61 Million | $-1.61 Million | $33.44K | ▼ -1617.6% |
| 2019 | -2.79x | $-3.59 Million | $-3.59 Million | $1.28 Million | ▲ +65.8% |
| 2017 | -8.16x | $-2.89 Million | $-2.89 Million | $353.52K | — |